The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

A new global report from the World Health Organization (WHO) Commission on Social Connection reveals that one in six people ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

The World Health Organization (WHO) has released a new policy brief entitled " Tuberculosis and primary health care: synergies and opportunities ...

The facility is fully accredited by the World Health Organization (WHO) and recognized as one of the most advanced polio ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...